Sign in to edit your profile (add interests, mentoring, photo, etc.)

    Henry Vanbrocklin, PhD

    SchoolUCSF School of Medicine
    Address185 Berry Street
    San Francisco CA 94143
    vCardDownload vCard

      Collapse Biography 
      Collapse Awards and Honors
      Molecular Imaging 2011Editor-in-Chief
      Society of Nuclear Medicine2006SNM Presidents Distinguished Service Award
      US Department of Energy1990Alexander Hollaender Distinguished Postdoctoral Fellow
      Society of Nuclear Medicine2010SNM Presidents Distinguished Service Award

      Collapse Overview 
      Collapse Overview
      Henry VanBrocklin, PhD, is a Professor in Residence, Director of the Radiopharmaceutical Research Program in the Center for Molecular and Functional Imaging (CMFI) at the University of California, San Francisco China Basin, and he is a Joint Faculty Scientist at the Lawrence Berkeley National Laboratory. Dr. VanBrocklin obtained his PhD in Radiopharmaceutical Chemistry from Washington University, St. Louis in 1990, and he completed a two-year postdoctoral program at the University of Illinois, Urbana in 1992. He maintains an active radiotracer research program in addition to providing tracers for collaborative basic science and translational clinical research. His research interests include short-lived radioisotope production to the creation of fluorine-18 and carcbon-11 labeling chemistry strategies for new radiotracer preparations and applications.

      Dr. VanBrocklin is one of the core faculty for the Master's in Biomedical Imaging (MSBI) program and a member of the MSBI executive committee.

      Dr. VanBrocklin was awarded the Alexander Hollaender Distinguished Postdoctoral Fellowship from the U.S. Department of Energy for developing positron-labeled estrogens, progestins, and androgens for tumor imaging. He has 70 published research articles.


      Short-lived radioisotope production to the creation of fluorine-18 and carbon-11 labeling chemistry strategies for new radiotracer preparations and applications, development of positron-labeled estrogens, progestin’s, androgens for tumor imaging

      Professional Interests:
      Developing radiopharmaceutical probes for PET and SPECT imaging applications including tracers for blood flow measurement, receptor-targeted tracers for prostate, pancreatic and breast cancer, and neurological imaging agents for neuroinflammation and excititory amino acid transport.

      Education and Training:
      • Doctor of Philosophy: Washington University, St. Louis - Radiopharmaceutical Chemistry
      • Postdoctoral Fellow: University of Illinois, Urbana

      Collapse Interests
      Developing radiopharmaceutical probes for PET and SPECT blood flow measurement and receptor-based targeted tracers for cancer, prostate, kidney, cancer.

      Collapse ORNG Applications 
      Collapse Websites
      Collapse NIH Awarded Grants
      Collapse Global Health

      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. LeBeau AM, Sevillano N, Markham K, Winter MB, Murphy ST, Hostetter DR, West J, Lowman H, Craik CS, VanBrocklin HF. Imaging active urokinase plasminogen activator in prostate cancer. Cancer Res. 2015 Apr 1; 75(7):1225-35.
        View in: PubMed
      People in Profiles who have published with this person.
      Related Authors
      People who share related concepts with this person.
      Back to TOP